Ignore This Picture
Spacer

Gastrointestinal Cancer Genetics Program

Select Publications from our Team

Katona B.W. and Rustgi A.K.  Gastric Cancer Genomics: Advances and Future Directions.  Cellular and Molecular Gastroenterology and Hepatology. 2017 Jan 14; 14;3(2):211-217. [PubMed]

Heeg S., Das K.K., Reichert M., Bakir B., Takano S., Caspers J., Aiello NM., Wu K., Neesse A., Maitra A., Iacobuzio-Donahue C.A., Hicks P., Rustgi A.K. ETS-Transcription Factor ETV1 Regulates Stromal Expansion and Metastasis in Pancreatic Cancer. Gastroenterology. 2016, 151(3): 540-553. [PubMed]

Bradbury A., Patrick-Miller L., Harris D., Stevens E., Egleston B., Smith K., Mueller R., Brandt A., Stopfer J., Rauch S., Forman A., Kim R., Fetzer D., Fleisher L., Daly M., Domchek S.  Utilizing Remote Real-Time Videoconferencing to Expand Access to Cancer Genetic Services in Community Practices: A Multicenter Feasibility Study.  Journal of Medical Internet Research. 2016, 18(2):e23. [PubMed]

Riff B.P., Katona B.W., Wilkerson M., Nathanson K.L., Metz D.C.  HNPCC-associated pheochromocytoma: expanding the tumor spectrum. Pancreas, 2015, 44(4): 676-8. [PubMed]

Bradbury A.R., Patrick-Miller L., Long J., Powers J., Stopfer J., Forman A., Rybak C., Mattie K., Brandt A., Chambers R., Chung W.K., Churpek J., Daly M.B., Digiovanni L., Farengo-Clark D., et al.  Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility.  Genetics in Medicine. 2015, 17: 485–492. [PubMed]

Katona B.W., Liu Y., Ma A., Jin J., Hua X.  EZH2 inhibition enhances the efficacy of an EGFR inhibitor in suppressing colon cancer cells. Cancer Biology & Therapy, 2014, 15(12): 1677-87. [PubMed]

Rustgi A.K.  Familial pancreatic cancer: genetic advances. Genes and Development. 2014, 28(1): 1-7. [PubMed]

Bonadies D.C., Brierley K.L., Barnett R.E., Baxter M.D., Donenberg T., Ducaine W.L., Ernst M.E., Homer J., Judkins M., Lovick N.M., Powers J.M., Stanislaw C., Stark E., Stenner R.C., Matloff E.T.  Adverse events in cancer genetic testing: the third case series. The Cancer Journal. 2014, 20(4): 246-53. [PubMed]

Moreira L., Balaguer F., Lindor N., de la Chapelle A., Hampel H., Aaltonen L.A., Hopper J.L., Le Marchand L., Gallinger S., Newcomb P.A., Haile R., THibodeau S.N., Gunawardena S., Jenkins M.A., Buchanan D.D., Potter J.D., Baron J.A., Ahnen D.J., Moreno V., Andreu M., Ponz de Leon M., Rustgi A.K., Castells A.; Identification of Lynch syndrome among patients with colorectal cancer. Journal of the American Medical Association.2012, 308(15): 1555-65. [PubMed]

King C.E., Cuatrecasas M., Castells A., Sepulveda A.R., Lee J.S., Rustgi A.K. LIN28B promotes colon cancer progression and metastasis. Cancer Research. 2011, 71(12): 4260-8. [PubMed]

Yang V.W., Lewis J., Wang T.C., Rustgi A.K. Colon cancer: an update and future directions.  Colon cancer: an update and future directions. Gastroenterology. 2010, 138(6): 2027-8. [PubMed]

Brandt AC, Tschirgi ML, Ready KJ, Sun C, Darilek S, Hecht J, Arun BK, Lu KH. Knowledge, attitudes, and clinical expereince of physicians regarding preimplantation genetic diagnosis for hereditary cancer predisposition syndromes. Familial Cancer. 2010 Sep;9(3);479-87. [PubMed]

Spacer
University of Pennsylvania | Perelman School of Medicine